Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Louise Nott"'
Autor:
Marjan M. Naeini, Felicity Newell, Lauren G. Aoude, Vanessa F. Bonazzi, Kalpana Patel, Guy Lampe, Lambros T. Koufariotis, Vanessa Lakis, Venkateswar Addala, Olga Kondrashova, Rebecca L. Johnston, Sowmya Sharma, Sandra Brosda, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu, Janine Thomas, Euan Walpole, G. Tao Mai, Stephen P. Ackland, Jarad Martin, Matthew Burge, Robert Finch, Christos S. Karapetis, Jenny Shannon, Louise Nott, Robert Bohmer, Kate Wilson, Elizabeth Barnes, John R. Zalcberg, B. Mark Smithers, John Simes, Timothy Price, Val Gebski, Katia Nones, David I. Watson, John V. Pearson, Andrew P. Barbour, Nicola Waddell
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Oesophageal adenocarcinoma is a poor prognosis cancer and the molecular features underpinning response to treatment remain unclear. We investigate whole genome, transcriptomic and methylation data from 115 oesophageal adenocarcinoma patients
Externí odkaz:
https://doaj.org/article/10a795104a0f4275aaca1728299e2389
Autor:
Anna Krelle, Vinod Kalapurackal Mathai, Geoff Kirkland, Louise Nott, Matthew D. Jose, Karen Whale
Publikováno v:
Cancer Reports, Vol 5, Iss 7, Pp n/a-n/a (2022)
Abstract Background Combination molecular targeted therapy with dabrafenib plus trametinib has been shown to improve progression‐free survival and overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. In general,
Externí odkaz:
https://doaj.org/article/576faa98aeea4cb8bc873437bb06defc
Autor:
Nathan Bain, Mike Nguyen, Lisa Grech, Daphne Day, Amelia McCartney, Kate Webber, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Louise Nott, Nada Hamad, Annette Tognela, Craig Underhill, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS Investigators
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1373 (2022)
Background: Vaccination is the cornerstone of the global public health response to the COVID-19 pandemic. Excess morbidity and mortality of COVID-19 infection is seen in people with cancer. COVID-19 vaccine hesitancy has been observed in this medical
Externí odkaz:
https://doaj.org/article/3ecd05934bfc454a9d051dc021580b30
Autor:
Daphne Day, Lisa Grech, Mike Nguyen, Nathan Bain, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Richard Blennerhassett, Louise Nott, Nada Hamad, Annette Tognela, David Hoffman, Amelia McCartney, Kate Webber, Jennifer Wong, Craig Underhill, Brett Sillars, Antony Winkel, Mark Savage, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators
Publikováno v:
Vaccines, Vol 10, Iss 6, p 851 (2022)
As COVID-19 vaccinations became available and were proven effective in preventing serious infection, uptake amongst individuals varied, including in medically vulnerable populations. This cross-sectional multi-site study examined vaccine uptake, hesi
Externí odkaz:
https://doaj.org/article/d55efc600f1647f7837aaf47093bbd8f
Autor:
David John Tobias McArdle, BA (Hons), MPsych (Clin Neuro), MBBS, Louise Nott, BMedSci, MBBS (Hons), FRACP, Robin Harle, MBBS, FRANZCR, John Patrick McArdle, MBBS, MD, FRCPA
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 4, Iss 3, Pp 210-215 (2018)
Ewing sarcoma is a highly aggressive small round cell malignant neoplasm of bone and soft tissue that typically is manifested in children and young adults. It is most commonly a primary bone tumor; however, extraosseous cases have been increasingly r
Externí odkaz:
https://doaj.org/article/aced245a64ee4265b6dc50f97eaa6b3a
Autor:
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle Cronk, Katharine Cuff, Anthony Dowling, Matthew George, Lisa Horvath, Elizabeth Hovey, Anthony Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence Krieger, Maitham Mathlum, Louise Nott, Zulfiquer Otty, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Stevanovic, Martin Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, Holly Campbell, Kim Chi, Joseph Chin, Edmond Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastien Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Eric Vigneault, Pawel Zalewski, Patrick Morris, Miriam O'Connor, Paul Donnellan, Dearbhaile O'Donnell, Jim Edwards, Peter Fong, Simon Crabb, Omar Khan, Vincent Khoo, Graham Macdonald, Heather Payne, Angus Robinson, Jonathon Shamash, John Staffurth, Carys Thomas
Publikováno v:
The Lancet Oncology. 24:323-334
Autor:
Matthew Loft, Sheau Wen Lok, Richard De Boer, Laeeq Malik, Sally Greenberg, Belinda Yeo, Angelyn Anton, Michelle Nottage, Vanessa Wong, Louise Nott, Ian M. Collins, Javier Torres, Frances Barnett, Janine M. Lombard, Peter Gibbs, Lucy Gately
Publikováno v:
Breast Cancer Research and Treatment. 198:67-74
Autor:
Sheau Wen Lok, Richard De Boer, Sally Baron‐Hay, Peter Button, Bianca Devitt, Benjamin C. Forster, Peter Fox, Michael Harold, Sahisha Ketheeswaran, Ganessan Kichenadasse, Belinda E. Kiely, Gavin Marx, Louise Nott, Laura Pellegrini, Ali Tafreshi, Peter Gibbs
Publikováno v:
International Journal of Cancer. 152:267-275
The pertuzumab study in the neoadjuvant setting for HER2+ nonmetastatic breast cancer in Australia (PeRSIA-ML39622) is an analysis of safety and effectiveness data from the pertuzumab patient registry. Although the prognosis of patients with early st
Autor:
Jeanne, Tie, Joshua D, Cohen, Kamel, Lahouel, Serigne N, Lo, Yuxuan, Wang, Suzanne, Kosmider, Rachel, Wong, Jeremy, Shapiro, Margaret, Lee, Sam, Harris, Adnan, Khattak, Matthew, Burge, Marion, Harris, James, Lynam, Louise, Nott, Fiona, Day, Theresa, Hayes, Sue-Anne, McLachlan, Belinda, Lee, Janine, Ptak, Natalie, Silliman, Lisa, Dobbyn, Maria, Popoli, Ralph, Hruban, Anne Marie, Lennon, Nicholas, Papadopoulos, Kenneth W, Kinzler, Bert, Vogelstein, Cristian, Tomasetti, Peter, Gibbs, Susanne, Kosmider
Publikováno v:
New England Journal of Medicine. 386:2261-2272
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its absence predicts a low risk of recurrence. The be
Autor:
J Connor Wells, Aven Sidhu, Keyue Ding, Martin Smoragiewicz, Daniel Y C Heng, Frances A Shepherd, Peter M Ellis, Penelope A Bradbury, Derek J Jonker, Lillian L Siu, Karen A Gelmon, Christos Karapetis, Jeremy Shapiro, Louise Nott, Christopher J O’Callaghan, Wendy R Parulekar, Lesley Seymour, Jose G Monzon
Publikováno v:
The Oncologist. 27:e286-e293
Background Complementary medicines (CM) are frequently used by patients with cancer. Controversy exists over the effectiveness and risk that CM may add to conventional cancer therapy. The incidence of CM use among patients enrolled in phase III clini